本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ocular Therapeutix

10.25
+0.38003.85%
成交量:10.75萬
成交額:109.04萬
市值:22.44億
市盈率:-7.25
高:10.25
開:10.09
低:10.06
收:9.87
52周最高:16.44
52周最低:6.23
股本:2.19億
流通股本:1.85億
量比:0.78
換手率:0.06%
股息:- -
股息率:- -
每股收益(TTM):-1.4140
每股收益(LYR):-1.4203
淨資產收益率:-72.99%
總資產收益率:-34.95%
市淨率:4.31
市盈率(LYR):-7.22

資料載入中...

2025/11/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/04

重要事件披露

Form 8-K - Current report
2025/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/30

重要事件披露

Form 8-K - Current report
2025/09/30

重要事件披露

Form 8-K - Current report
2025/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/05

重要事件披露

Form 8-K - Current report
2025/06/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/06/11

重要事件披露

Form 8-K - Current report